TREM2 and prostate adenocarcinoma: Moreover, analysis of PFI data revealed an association between low TREM2 methylation level and poor prognosis in patients with KICH, kidney renal papillary cell carcinoma, LGG, MESO, and PRAD (Figure 12E).